C4 Therapeutics, Inc. - Common Stock (CCCC)

$45.94 1.14 (2.54%)
16:00 EDT CCCC Stock Quote Delayed 30 Minutes
Robert Lakin

ISR Stock: Why Little-Known Isoray Is Surging 200% Today

By Robert Lakin, InvestorPlace Contributor
An FDA nod on Isoray's prostate treatment using brachytherapy seeds sent ISR stock skyrocketing. There's risk with uncertain reward in this biopharma stock.
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.98B
PE Ratio 3.56
EPS 12.89
Volume (Avg. Vol.) 856,150
Day's Range 44.25 - 47.50
52-Week Range 22.40 - 48.97
Dividend & Yield N/A (N/A)